Editor’s Observe: If you happen to or somebody you recognize is battling suicidal ideas or psychological well being issues, please name the 988 Suicide & Disaster Lifeline by dialing 988 to attach with a skilled counselor, or go to the 988 Lifeline website.
CNN
—
Individuals taking semaglutide, the favored treatment for diabetes and weight reduction, usually tend to report having ideas of suicide in contrast with these taking different medicine, in line with a brand new research of a global drug security database. However the discovering is the most recent see-saw of scientific proof on the danger of melancholy and suicide tied to the favored medicines — and critics say proof that the medicine trigger issues with temper is restricted.
Semaglutide is bought beneath the model title Ozempic when it’s prescribed for diabetes and Wegovy when it’s prescribed for weight reduction. As well as, plenty of firms make compounded types of the drug. Using the treatment has surged lately, and research have proven extra promising results, together with reductions in kidney disease and cancer.
However suicide has been a long-standing concern with medicines that alter the need for meals. For some individuals, dropping the pleasure and reward of consuming — and perhaps other things — creates a dramatic shift in temper and will enhance the danger of self-harm. In 2008, the load loss drug rimonabant, which acted on the identical mind system that offers individuals the munchies once they’re on marijuana, was withdrawn from use as a result of it elevated the danger of suicide. (The drug was by no means authorised to be used in the USA.)
The patient information for semaglutide already features a warning to be careful for melancholy and suicidal ideas. However there’s been conflicting proof in regards to the danger of suicidal ideas and emotions with new weight reduction medicine, together with semaglutide.
Earlier this 12 months, the European Medicines Agency stated accessible proof didn’t present a hyperlink between suicide and semaglutide and different medicine used for weight reduction. The US Meals and Drug Administration has additionally been investigating the danger of suicide and suicidal ideas throughout medicine in the identical class as semaglutide and up to now has not discovered any elevated danger. Nonetheless, the company says it may possibly’t rule out a small enhance in danger due to the small complete variety of occasions of their surveillance methods, and its investigation is ongoing.
A large study revealed in January within the journal Nature Drugs discovered that use of semaglutide was linked to a decrease danger of suicidal ideas, in contrast with individuals taking completely different sorts of medicines for weight reduction and diabetes.
The new study, which was revealed Tuesday within the journal JAMA Community Open, checked out studies of suicidal ideas in individuals taking semaglutide — whether or not for diabetes or weight reduction — in a database maintained by the World Well being Group that compiles antagonistic occasions linked to medicine throughout 140 nations.
The research authors discovered 107 studies of sufferers, out of greater than 30,500 complete, who stated they considered killing themselves whereas taking semaglutide and 162 related studies, out of greater than 52,000, in sufferers taking liraglutide, a distinct injected diabetes treatment that’s in the identical class as semaglutide. Liraglutide is an older drug, so extra individuals have had expertise taking it.
The research authors discovered what they describe as a disproportional danger of suicidal ideas in individuals taking semaglutide however not in individuals who had been taking liraglutide. After they in contrast studies of suicidal ideas in individuals taking semaglutide with the danger reported with all different medicine within the database, they discovered that the danger was elevated by about 45% in individuals taking semaglutide.
The chance was about 4 occasions greater in individuals who had been additionally taking medicine to manage melancholy and nervousness, suggesting that this group could also be at even greater danger for temper results with these medicines. When the research authors excluded circumstances of individuals taking semaglutide and antidepressants, the affiliation disappeared — suggesting that individuals who had been taking each medicine had been driving the danger.
The research authors acknowledge that their analysis has limitations. However as a result of so many individuals are taking semaglutide, they suppose the findings warrant additional research and “pressing clarification” in regards to the danger.
Different consultants stated the proof offered within the research is skinny.
“Principally, it’s arduous to tease out from this research whether or not it’s the drug doing this or the temper dysfunction,” stated Dr. Mahyar Etminan, an skilled in drug security on the College of British Columbia in Vancouver who was not concerned within the research
Get CNN Well being’s weekly e-newsletter
“This paper presents, at greatest, weak proof of an affiliation between semaglutide and suicidality,” stated Ian Douglas, a professor of pharmacoepidemiology on the London College of Hygiene & Tropical Drugs. In a remark given to reporters, Douglas says research like this are good for producing theories however can’t show trigger and impact.
In a commentary on the research, Dr. Francesco Salvo and Dr. Jean-Luc Faillie, two French drug security researchers who weren’t concerned within the analysis, agree. They are saying it’s frequent for drug security research to fluctuate of their conclusions relying on the database that’s used and the strategies of the research. Till we have now higher proof, it’s a good suggestion to watch out, they are saying.
“Despair or suicidality are uncommon however extraordinarily extreme occasions and must be prevented and managed as a lot as doable,” Salvo and Faillie wrote.
With out extra exact information, they suppose GLP-1 and different kinds of urge for food suppressants must be prescribed with warning in individuals with a historical past of melancholy or suicidal ideas. And if sufferers expertise a brand new episode of melancholy whereas on the treatment, they wrote, medical doctors could wish to take into account “quick discontinuation.”